Stephanie Weinstein
Overview
Explore the profile of Stephanie Weinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
3443
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang A, Shen J, Rodriguez A, Saunders E, Chen F, Janivara R, et al.
Nat Genet
. 2023 Nov;
55(12):2065-2074.
PMID: 37945903
The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry...
2.
Berndt S, Vijai J, Benavente Y, Camp N, Nieters A, Wang Z, et al.
Leukemia
. 2023 Sep;
37(10):2142.
PMID: 37666943
No abstract available.
3.
Darst B, Shen J, Madduri R, Rodriguez A, Xiao Y, Sheng X, et al.
Am J Hum Genet
. 2023 Jun;
110(7):1200-1206.
PMID: 37311464
Genome-wide polygenic risk scores (GW-PRSs) have been reported to have better predictive ability than PRSs based on genome-wide significance thresholds across numerous traits. We compared the predictive ability of several...
4.
Darst B, Shen J, Madduri R, Rodriguez A, Xiao Y, Sheng X, et al.
medRxiv
. 2023 Jun;
PMID: 37292833
Genome-wide polygenic risk scores (GW-PRS) have been reported to have better predictive ability than PRS based on genome-wide significance thresholds across numerous traits. We compared the predictive ability of several...
5.
Feng X, Wu W, Onwuka J, Haider Z, Alcala K, Smith-Byrne K, et al.
J Natl Cancer Inst
. 2023 Jun;
115(9):1050-1059.
PMID: 37260165
Background: We sought to develop a proteomics-based risk model for lung cancer and evaluate its risk-discriminatory performance in comparison with a smoking-based risk model (PLCOm2012) and a commercially available autoantibody...
6.
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al.
Nat Genet
. 2023 Feb;
55(3):519-520.
PMID: 36782065
No abstract available.
7.
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al.
Nat Genet
. 2022 Dec;
55(1):89-99.
PMID: 36539618
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide association study meta-analysis of 100,204 CRC cases and 154,587 controls of European and east Asian ancestry,...
8.
Berndt S, Vijai J, Benavente Y, Camp N, Nieters A, Wang Z, et al.
Leukemia
. 2022 Oct;
36(12):2835-2844.
PMID: 36273105
Lymphoma risk is elevated for relatives with common non-Hodgkin lymphoma (NHL) subtypes, suggesting shared genetic susceptibility across subtypes. To evaluate the extent of mutual heritability among NHL subtypes and discover...
9.
Singh A, Lavin J, DiStefano C, Chon E, Weinstein S, Slutsky S, et al.
Front Oral Health
. 2022 Aug;
3:923124.
PMID: 35990504
Introduction: Advocacy involves promoting a noble cause or voicing on behalf of a program, policy, or population group. Previous literature shows that dentists who provide services to Medicaid-enrolled, underserved, and...
10.
Wu H, Weinstein S, Moore L, Albanes D, Wilson R
Cancer Causes Control
. 2021 Oct;
33(1):91-99.
PMID: 34652593
Purpose: To determine whether higher coffee intake may reduce the risk of renal cell cancer (RCC) associated with lead (Pb) and other heavy metals with known renal toxicity. Methods: We...